IPO News

Upcoming and recent IPOs, SPAC mergers, and direct listings. Track new stock market listings, IPO pricing, and first-day trading performance.

Exascale Labs Debuts on Nasdaq, Shares Jump 12% Despite Funding Gap
IPO Michael Okonkwo

Exascale Labs Debuts on Nasdaq, Shares Jump 12% Despite Funding Gap

Exascale Labs (XLAB) rose 12% in its Nasdaq debut, but a $12M cash balance against a $300M pipeline signals a funding gap for AI infrastructure growth.

Pasqal Soars 55% in Nasdaq Debut After $2B Quantum Merger
IPO Michael Okonkwo

Pasqal Soars 55% in Nasdaq Debut After $2B Quantum Merger

Pasqal shares jumped 54.7% to $15.14 on Nasdaq debut after $2B merger, while rivals IonQ, Rigetti, D-Wave, and Quantum Computing declined.

IONQ RGTI QBTS QUBT
Cre8 Enterprise Stock Soars 165% on Record IPO Workload
IPO Michael Okonkwo

Cre8 Enterprise Stock Soars 165% on Record IPO Workload

Cre8 Enterprise shares surged 165% after reporting record customer activity and a 482% jump in Hong Kong IPO submissions, adding $8.5 million in market value.

CRE QUAD EBF
Generate Biomedicines Plunges 20% as Lock-Up Expiry Floods Market
IPO Michael Okonkwo

Generate Biomedicines Plunges 20% as Lock-Up Expiry Floods Market

Generate Biomedicines (GENB) shares fell 20% as a 103.14 million-share lock-up expired, quadrupling the tradable float and heightening supply worries.

Generate Biomedicines Surges 12% Ahead of Lockup Expiry
IPO Michael Okonkwo

Generate Biomedicines Surges 12% Ahead of Lockup Expiry

Generate Biomedicines (GENB) shares jumped 12.3% ahead of the expiration of a 103.14 million-share lockup, with trading volume nearly four times the average.

SpaceX Share Unlock Tests SPCX Liquidity Near IPO Price
IPO Michael Okonkwo

SpaceX Share Unlock Tests SPCX Liquidity Near IPO Price

SpaceX's 319 million-share unlock pressured SPCX near its $135 IPO price. Shares closed at $136.97, with analysts split on valuation.

MS
Werewolf Therapeutics Stock Doubles on Ambros Merger; Legacy Holders Get 6.8%
IPO Michael Okonkwo

Werewolf Therapeutics Stock Doubles on Ambros Merger; Legacy Holders Get 6.8%

Werewolf Therapeutics shares doubled after announcing a merger with Ambros Therapeutics. Existing shareholders will hold only 6.8% of the combined entity, with a $150 million PIPE funding the lead drug program.

HOWL
SpaceX Shares Slide 5.6% as 319 Million Insider Shares Become Tradable
IPO Michael Okonkwo

SpaceX Shares Slide 5.6% as 319 Million Insider Shares Become Tradable

SpaceX shares dropped 5.6% as 319 million insider shares unlocked, wiping out $103 billion in market value. Trading volume was thin, and analysts remain split.

SpaceX Shares Slide 2.6% as 319 Million-Share Lockup Expiry Looms
IPO Michael Okonkwo

SpaceX Shares Slide 2.6% as 319 Million-Share Lockup Expiry Looms

SpaceX shares dropped 2.6% to $139.65 as a 319 million-share lockup expiry approaches, representing 4.4 times Wednesday's volume. The stock remains 3.4% above its IPO price.

CXMT's $586B Valuation Hinges on Tiny 6.7% Float
IPO Michael Okonkwo

CXMT's $586B Valuation Hinges on Tiny 6.7% Float

CXMT's $586B market cap is supported by only 6.7% tradable shares, amplifying volatility. The stock fell 2.77% to ¥57.55, but remains up 7.5% since Aug. 12.

MU SSNLF
Unitree Robotics Soars 460% in Shanghai Debut
IPO Michael Okonkwo

Unitree Robotics Soars 460% in Shanghai Debut

Unitree Technology's shares skyrocketed 460% on its first day of trading in Shanghai, closing at RMB 845 and valuing the robot maker at $50 billion.

TCEHY BABA
AMY Grupo IPO Aims to Raise VND 787 Billion, Debt Repayment Takes Priority
IPO Michael Okonkwo

AMY Grupo IPO Aims to Raise VND 787 Billion, Debt Repayment Takes Priority

AMY Grupo's IPO enters payment phase, raising VND 787 billion. Most funds go to debt reduction, not expansion, as shares await October listing.